Cabaletta Bio, Inc.
CABA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001759138
No open-market purchases or sales by Cabaletta Bio, Inc. insiders were filed in the last 90 days; 139 institutions reported holding it in 13F filings for Q2 2026, worth $490.4M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Cabaletta Bio, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 128
- +32 vs. Q3 2023
- Shares held
- 48.5M
- +7.65M (+18.7%) vs. Q3 2023
- Total value
- $1.10B
- +$479.6M (+77.1%) vs. Q3 2023
- New holders
- 42
- 41 more added
- Sold out
- 10
- 31 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CABA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 139 | $490.4M |
| Q1 2026 | 108 | $227.5M |
| Q4 2025 | 95 | $166.9M |
| Q3 2025 | 75 | $162.0M |
| Q2 2025 | 86 | $110.7M |
| Q1 2025 | 93 | $50.3M |
| Q4 2024 | 109 | $87.2M |
| Q3 2024 | 120 | $226.7M |
| Q2 2024 | 142 | $380.0M |
| Q1 2024 | 159 | $870.9M |
| Q4 2023 | 128 | $1.10B |
| Q3 2023 | 97 | $622.6M |
| Q2 2023 | 84 | $470.5M |
| Q1 2023 | 72 | $203.9M |
| Q4 2022 | 61 | $183.9M |
| Q3 2022 | 54 | $7.76M |
| Q2 2022 | 55 | $17.8M |
| Q1 2022 | 62 | $36.9M |
| Q4 2021 | 66 | $68.9M |
| Q3 2021 | 61 | $211.3M |
| Q2 2021 | 63 | $135.5M |
| Q1 2021 | 68 | $180.1M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Cabaletta Bio, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SG Americas Securities, LLC | 9,740 | $221.0K | 0.00% | +9,740 | New |
| China Universal Asset Management Co., Ltd. | 4,962 | $112.6K | 0.02% | +4,962 | New |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 4,739 | $107.6K | 0.00% | −2,800−37.1% | Reduced |
| Amalgamated Bank | 4,704 | $107.0K | 0.00% | +56+1.2% | Added |
| Virtus ETF Advisers LLC | 4,507 | $102.3K | 0.06% | +4,507 | New |
| Ameritas Investment Partners, Inc. | 3,452 | $78.4K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 3,397 | $77.1K | 0.00% | +3,397 | New |
| Lazard Asset Management LLC | 3,403 | $76.0K | 0.00% | +118+3.6% | Added |
| Tower Research Capital LLC (TRC) | 2,623 | $59.5K | 0.00% | +1,042+65.9% | Added |
| First Manhattan Co | 2,600 | $59.0K | 0.00% | −115,000−97.8% | Reduced |
| Metropolitan Life Insurance Co | 2,021 | $45.9K | 0.00% | 00.0% | Unchanged |
| Comerica Bank | 1,943 | $44.1K | 0.00% | −85−4.2% | Reduced |
| Quantbot Technologies LP | 1,500 | $34.0K | 0.00% | +1,500 | New |
| Allspring Global Investments Holdings, LLC | 1,164 | $26.4K | 0.00% | −2,972−71.9% | Reduced |
| Macroview Investment Management LLC | 1,131 | $25.7K | 0.03% | +1,131 | New |
| The PNC Financial Services Group, Inc. | 690 | $15.7K | 0.00% | −96−12.2% | Reduced |
| Private Trust Co NA | 653 | $14.8K | 0.00% | +156+31.4% | Added |
| FMR LLC | 405 | $9.19K | 0.00% | −387−48.9% | Reduced |
| Federation des caisses Desjardins du Quebec | 340 | $7.72K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 274 | $6.22K | 0.00% | +274 | New |
| Fortitude Family Office, LLC | 262 | $5.95K | 0.00% | +262 | New |
| Daiwa Securities Group Inc. | 175 | $4.00K | 0.00% | +175 | New |
| Federated Hermes, Inc. | 132 | $3.00K | 0.00% | +74+127.6% | Added |
| Capital Advisors, Ltd. LLC | 81 | $2.00K | 0.00% | 00.0% | Unchanged |
| Beaird Harris Wealth Management, LLC | 79 | $1.79K | 0.00% | 00.0% | Unchanged |
| Bogart Wealth, LLC | 50 | $1.14K | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 23 | $522 | 0.00% | 00.0% | Unchanged |
| GAMMA Investing LLC | 14 | $287 | 0.00% | +14 | New |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −2,879,424−100.0% | Sold out |
| Velan Capital Investment Management LP | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Putnam Investments LLC | 0 | $0 | 0.00% | −58,934−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −55,156−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −48,332−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −25,631−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −10,123−100.0% | Sold out |
| WR Wealth Planners, LLC | 0 | $0 | 0.00% | −900−100.0% | Sold out |
| Authentikos Wealth Advisory, LLC | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| First Republic Investment Management, Inc. | – | – | – | – | Not filed |